Gianna Melillo

Findings are based on a case-control study carried out in Brazil.

Skin rashes are common among patients who complete hematopoietic cell transplantation (HCT).

The pilot program for pulmonary arterial hypertension (PAH) was carried out at a single center in the Netherlands.

Lower socioeconomic status (SES) was not linked with hidradenitis suppurativa (HS) in minors, but was associated with obesity and tobacco use in this age group.

Authors concluded more research is needed to understand both patient level and structural barriers to inequitable access to multiple myeloma (MM) care in Canada.

Findings are based on a meta-analysis of 51 studies and 739 pregnancies.

Researchers assessed overall survival outcomes in patients in France.

The decreasing cost of DNA sequencing has contributed to an uptick in genomic sequencing for precision diagnostics in rare diseases.

The new classifications included several major changes and may help identify different subtypes.

It’s estimated around 20% of patients will discontinue their first course of anti–tumor necrosis factor-α (anti–TNF-α) and rates increase over time

Results are based on a study of low-dose interleukin-2 (IL-2) carried out at Dana-Farber Cancer Institute.

To the authors’ knowledge, the study is the first to include a patient with essential thrombocythemia (ET) and MPL and Type 1 calreticulin gene mutations.

Although methotrexate was linked with a higher risk of anemia, it carried risks of kidney and other serious infections similar to those of biologics.

Higher enablement was associated with being more comfortable to reconsult about persistent or worsening symptoms.

Ixazomib was first approved in the United States in 2015 for relapsed/refractory multiple myeloma.

To stratify the risk of future epilepsy, physicians have historically used lumbar puncture, neuroimaging, and electroencephalography in these patients.

Patients with psoriasis taking methotrexate are nearly 3 times as likely to develop non-melanoma skin cancer than patients not taking the treatment.

Results are based off of data from the Florida Behavioral Risk Factor Surveillance System.

Researchers took both the learning curve of the new process and the COVID-19 pandemic into consideration.

Although the condition is rare and cases are limited, researchers were able to generally conclude vagal nerve stimulation (VNS) serves as a well-tolerated intervention.

After 1 year, overall treatment switch rates were 14.4%, while after 2 years, switch rates were 26%.

Data suggest a substantial reliance on established therapies for polycythemia vera, despite access to all available treatment options.

Authors offered specific recommendations for improving publishing and adoption of algorithmic processes focused on type 2 diabetes (T2D) going forward.

Strict inclusion and exclusion criteria in clinical trials means findings on health-related quality of life (HRQOL) may not be generalizable to the real-world setting.

Immune checkpoint inhibitors (ICIs) can increase life expectancy among patients who have non–small cell lung cancer (NSCLC), but they also carry the risk of immune-related adverse events.

Researchers suggest socioeconomic status (SES) be considered in prognostic algorithms going forward.

Budd-Chiari syndrome and myeloproliferative neoplasms (MPNs) are rare, which means available data are limited.

New study findings show this risk was higher among children born prematurely or whose mother was classified as having low socioeconomic status.

The study identified 3 themes related to diabetes self-care in patients who have type 1 diabetes (T1D), including emotional stress and anxiety and concerns regarding the COVID-19 pandemic.

Researchers compared chimeric antigen receptor T-cell therapies axicabtagene ciloleucel (axi-cel) and tisagenlecleucel.